Literature DB >> 8986199

Genetic predisposition to organ-specific endpoints of alcoholism.

T Reed1, W F Page, R J Viken, J C Christian.   

Abstract

Medical records of the 15,924 twin-pairs in the National Academy of Sciences-National Research Council (NAS-NRC) twin registry were collected for an additional 16 years through 1994 when the surviving twins were aged 67 to 77 years. Compared with earlier analyses (Hrubec, Z, and Omenn, G. S., Alcohol. Clin. Exp. Res., 5:207-215, 1981), when subjects were aged 51 to 61, there were 23% more diagnoses of alcoholism (34.4 per 1,000 prevalence), 32% more diagnoses of alcoholic psychosis (5.4 per 1,000), and 25% more twins with liver cirrhosis (17.7 per 1,000). Overall, 5.3% of the cohort had at least one of the diagnoses related to alcoholism. Probandwise concordance rates (%) were: alcoholism-26.7 monozygotic (MZ), 12.2 dizygotic (DZ) (p < 0.0001); alcoholic psychosis-17.3 MZ, 4.8 DZ (p < 0.05); and cirrhosis-16.9 MZ, 5.3 DZ (p < 0.001). Concordance for any diagnosis related to alcoholism was 30.2 MZ, 13.9 DZ (p < 0.0001). Maximum-likelihood modeling indicated that approximately 50% of the overall variance was due to additive genetic effects; in all diagnosis categories, a totally environmental model gave a significantly poorer fit to the data. Bivariate and trivariate genetic analyses indicated most of the genetic liability for the organ-specific endpoints of psychosis and cirrhosis was due to the shared genetic liability for alcoholism. Once the shared variance with alcoholism was considered, there was no further shared genetic liability for psychosis and cirrhosis. Our results confirm Hrubec and Omenn's conclusion that there was significantly greater concordance in MZ twins-pairs for alcoholic psychosis and cirrhosis in the NAS-NRC twins, and concordance rates remained similar to those reported 16 years earlier. In contrast, we found most of the genetic liability to organ-specific complications of alcoholism was shared with the genetic liability for alcoholism per se; only a small portion of the genetic variance of the individual complications was independent of the genetic predisposition for alcoholism.

Entities:  

Mesh:

Year:  1996        PMID: 8986199     DOI: 10.1111/j.1530-0277.1996.tb01695.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  43 in total

1.  Subjective perceptions associated with the ascending and descending slopes of breath alcohol exposure vary with recent drinking history.

Authors:  Leah Wetherill; Sandra L Morzorati; Tatiana Foroud; Kyle Windisch; Todd Darlington; Ulrich S Zimmerman; Martin H Plawecki; Sean J O'Connor
Journal:  Alcohol Clin Exp Res       Date:  2011-09-20       Impact factor: 3.455

Review 2.  Disentangling the complex association between childhood sexual abuse and alcohol-related problems: a review of methodological issues and approaches.

Authors:  Carolyn E Sartor; Arpana Agrawal; Vivia V McCutcheon; Alexis E Duncan; Michael T Lynskey
Journal:  J Stud Alcohol Drugs       Date:  2008-09       Impact factor: 2.582

3.  An extended Swedish national adoption study of alcohol use disorder.

Authors:  Kenneth S Kendler; Jianguang Ji; Alexis C Edwards; Henrik Ohlsson; Jan Sundquist; Kristina Sundquist
Journal:  JAMA Psychiatry       Date:  2015-03       Impact factor: 21.596

4.  A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis.

Authors:  Stephan Buch; Felix Stickel; Eric Trépo; Michael Way; Alexander Herrmann; Hans Dieter Nischalke; Mario Brosch; Jonas Rosendahl; Thomas Berg; Monika Ridinger; Marcella Rietschel; Andrew McQuillin; Josef Frank; Falk Kiefer; Stefan Schreiber; Wolfgang Lieb; Michael Soyka; Nasser Semmo; Elmar Aigner; Christian Datz; Renate Schmelz; Stefan Brückner; Sebastian Zeissig; Anna-Magdalena Stephan; Norbert Wodarz; Jacques Devière; Nicolas Clumeck; Christoph Sarrazin; Frank Lammert; Thierry Gustot; Pierre Deltenre; Henry Völzke; Markus M Lerch; Julia Mayerle; Florian Eyer; Clemens Schafmayer; Sven Cichon; Markus M Nöthen; Michael Nothnagel; David Ellinghaus; Klaus Huse; Andre Franke; Steffen Zopf; Claus Hellerbrand; Christophe Moreno; Denis Franchimont; Marsha Y Morgan; Jochen Hampe
Journal:  Nat Genet       Date:  2015-10-19       Impact factor: 38.330

5.  Single-nucleotide rs738409 polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in Han Chinese males.

Authors:  Yanfang Zhang; Tongsheng Guo; Funing Yang; Yuanli Mao; Liubing Li; Chenxi Liu; Qiang Sun; Yongzhe Li; Jing Huang
Journal:  Hepatol Int       Date:  2018-08-21       Impact factor: 6.047

6.  Common genetic and environmental contributions to post-traumatic stress disorder and alcohol dependence in young women.

Authors:  C E Sartor; V V McCutcheon; N E Pommer; E C Nelson; J D Grant; A E Duncan; M Waldron; K K Bucholz; P A F Madden; A C Heath
Journal:  Psychol Med       Date:  2010-11-08       Impact factor: 7.723

Review 7.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 8.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

Review 9.  PNPLA3 genetic variation in alcoholic steatosis and liver disease progression.

Authors:  Felix Stickel; Jochen Hampe; Eric Trépo; Christian Datz; Stefano Romeo
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

Review 10.  Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma.

Authors:  Lydia Giannitrapani; Maurizio Soresi; Daniele Balasus; Anna Licata; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.